Aldeyra Therapeutics (ALDX) Tops Q2 EPS by 3c

August 10, 2016 7:20 AM EDT
Get Alerts ALDX Hot Sheet
Trade ALDX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.41), $0.03 better than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment